ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

EDEN Eden Research Plc

3.90
0.10 (2.63%)
Last Updated: 08:18:36
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Eden Research Plc LSE:EDEN London Ordinary Share GB0001646941 ORD 1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.10 2.63% 3.90 3.80 4.00 3.90 3.80 3.80 132,766 08:18:36
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Biological Pds,ex Diagnstics 3.19M -6.49M -0.0122 -3.20 20.27M
Eden Research Plc is listed in the Biological Pds,ex Diagnstics sector of the London Stock Exchange with ticker EDEN. The last closing price for Eden Research was 3.80p. Over the last year, Eden Research shares have traded in a share price range of 3.50p to 7.25p.

Eden Research currently has 533,352,523 shares in issue. The market capitalisation of Eden Research is £20.27 million. Eden Research has a price to earnings ratio (PE ratio) of -3.20.

Eden Research Share Discussion Threads

Showing 19551 to 19569 of 19650 messages
Chat Pages: 786  785  784  783  782  781  780  779  778  777  776  775  Older
DateSubjectAuthorDiscuss
10/11/2024
22:15
Impression,

Tenfold Sipcam, Eden and Corteva have hatched a plan.

Mevalone roll out in the USA is being delayed by unstated '10-fold growth in the overall addressable Market strategy' and Sipcam capacity build combined with financial confidence and thus share price support guaranteed by Corteva with Ecovelex full EU approval for 2025.

supersonico
10/11/2024
17:50
Tenfold is numerate and impressive
alchemy
10/11/2024
08:22
Stone Fruits;

"There is significant future potential to expand the use of Mevalone for the treatment of powdery and downy mildews and field trials for these applications on grapes are currently underway, with the potential to expand further to include crops such as berries and stone fruits. All expanded uses of Mevalone are, as always, subject to regulatory approval, which is anticipated in the coming years"



............................................

Investingisatrickygame - 26 Jun 2024 - 11:09:46 - 17852 of 19160 Eden Research - EDEN
It does imply that this approval will lead to other regulators viewing this and actioning the same. I'm looking at Almonds in California!

Investingisatrickygame - 24 Jun 2024 - 08:44:55 - 17840 of 19159 Eden Research - EDEN
California produces 80% of the world's Almonds and is 100% of US production.

Californian Almond crop production is expected to be 21% higher in 2024 over 2023.

Almonds are California's 3rd most valuable crop. I fully expect Sipcam to get that label extension.

...................................................

Biofungicide Label Extension in Spain 24 June 2024

This newly expanded label makes Araw one of the most versatile and reliable solutions to prevent fungal diseases in many crops under organic and conventional agriculture. Thanks to this new authorisation, obtained through Sipcam's local regulatory team, all relevant horticultural crops in Spain can now be protected with Araw representing an excellent opportunity in several crops of growing importance, such as avocado, mango, and almond, which has become the third largest tree crop in Spain after olives and grapes. Spain boasts the largest cultivated area of almond trees in the world and ranks third in terms of overall production. Eden anticipates that this growth of the addressable market for Araw will contribute to revenue in 2025 and beyond. Further details of this expansion will be provided in due course as commercialisation commences.

Sean Smith, Chief Executive Officer of Eden Research, commented:

"Today's announcement is an excellent demonstration of our strategy to pursue growth opportunities through both new product introductions and with existing products by targeting new crop types and new disease targets. We are delighted to build on the success of our longstanding relationship with Sipcam. They have done an outstanding job of making the Iberian region an important and strong revenue-generating territory for the Company. This label extension represents a significant additional growth opportunity for us. It not only includes numerous new crops and diseases, but it also includes a number of high-value crops that are particularly disease prone."

supersonico
10/11/2024
08:14
15 December 2022

Eden Research Plc

("Eden" or "Company")

Distribution Agreement for Mevalone in France



Eden Research plc (AIM: EDEN), the AIM-quoted company focused on sustainable biopesticides and plastic-free formulation technology for use in the global crop protection, animal health and consumer products industries, announces that it has signed an agreement ("Agreement") with Corteva France ("Corteva") which allows Corteva to market, distribute and sell Eden's fungicide product, Mevalone®, in France on an exclusive basis.



Mevalone is Eden's flagship, sustainable, foliar biofungicide, which is used to treat Botrytis cinerea on grapes and various other crops, a fungal disease commonly found in crops exposed to humid conditions. Eden also recently received authorisation for the use of Mevalone on pome fruits, including apples and pears, in France to help treat post-harvest diseases that arise during storage, thereby significantly reducing food waste.
....................................................................

There is significant future potential to expand the use of Mevalone for the treatment of powdery and downy mildews and field trials for these applications on grapes are currently underway, with the potential to expand further to include crops such as berries and stone fruits. All expanded uses of Mevalone are, as always, subject to regulatory approval, which is anticipated in the coming years.

.............................................................

France is widely recognised for its agricultural output, which is well-known for its high quality. France's vineyards are the country's biggest consumers of plant protection products, which include fungicides, insecticides, and herbicides. Although viticulture represents just 3% of France's agricultural land, the sector consumes 20% of the country's fungicides. It also represents 15% of French agricultural produce in value terms; an exciting landscape in which Eden's biopesticides will play an expanded role.

The Agreement with Corteva will be implemented immediately with commercial progress expected over the course of the next year as Eden transitions from its current distribution arrangements.

Sean Smith, CEO of Eden Research plc, commented:

"Expanding our partnership with agriscience powerhouse Corteva reflects the further execution and acceleration of Eden's commercial strategy. Eden has a strong existing partnership with Corteva with our ongoing collaboration around the development of seed treatments, and this Agreement marks the expansion of our relationship with the focus of this Agreement being to increase Eden's commercial presence in the all-important French grape and pome fruits markets.

"Corteva's vast presence in France will enable Eden to capitalise on the significant commercial opportunities that exist within this expansive market and has strong potential to increase Eden's product sales revenue. Coupled with our recently received EPA approval in the US, this Agreement highlights the global demand for sustainable biopesticides and the strides Eden is making to broaden its global footprint and accelerate commercial growth."

Sylvain Bedel, Managing Director of Corteva France said:

"We are pleased to be expanding our working relationship with Eden by supplying to farmers Eden's innovative bio-solutions in the French market. There is a strong demand for more sustainable growing practices in France and farmers are paying increasing attention to consumer demand for such practices. Eden's unique technology helps provide a much-needed solution."

supersonico
10/11/2024
07:57
Master Investor Show 2023 - Sean Smith

"we're currently working with one of our
partners corteva in France to grow the addressable
Market by about 10 fold on the back of
new regulatory clearance so we're going
to transition from a market that is
really just botrytis on grapes and
storage disease on apples to a market
that is those plus new disease targets
which will ultimately translate into a

10-fold growth in the overall addressable Market in France and we're busy doing the same thing elsewhere as well".



Smith , Sipcam "building their sustainable pesticide business in the US largely around Mevalone so we've all been eagerly anticipating this, they have absolutely hit the ground running"

@3m..

supersonico
09/11/2024
12:35
WHAT THESE RAMPING LIARS - trapped bulls and paid ramper alike - do NOT want you to look at, ROTFLMAO!!!!
neutralpov
09/11/2024
11:57
Question,
What's going on here? More studies?

Are we seeing the preparation of 10X Corteva French model to coincide with Sipcam's enhanced Waynesboro US production capacity @18101 ? ..

Smith , Sipcam "building their sustainable pesticide business in the US largely around Mevalone so we've all been eagerly anticipating this, they have absolutely hit the ground running"

@3m..

Parallel French / USA label enhancement ? ... or nothing to see here?

12 May 2023 Regulatory approvals in California and Florida (Mevalone)

These approvals follow regulatory authorisation from the United States Environmental Protection Agency (EPA) in September 2022 for all six petitions submitted by Eden (three active ingredients, two formulated products and Eden's Sustaine® polymer-free encapsulation technology; making up the building blocks of current and future products), .

9 January 2024

Brent Marek, CEO of Sipcam Agro USA, commented: "Mevalone is a highly effective, sustainable biofungicide. Mevalone provides the perfect natural solution for farmers in California adopting more sustainable growing practices. Sipcam Oxon SpA has enjoyed several years of success with Mevalone in key European countries such as Italy and Spain, and we look forward to working with the Eden team to bring this product to California, which is a significant addressable market in the US considering its production of high value crops such as grapes."

07 November 2024

Sales of Mevalone in the US were constrained in 2024 due to the timing of the approval in California (January 2024) which meant that it wasn't possible for Eden's distributor to undertake a full marketing campaign. In addition, the label of Mevalone, as approved in the US, has certain restrictions which may negatively impact sales in the short term. The Company is currently addressing these restrictions through studies, and the successful outcome of these should result in an increase in addressable market in the short to medium-term.

supersonico
09/11/2024
08:07
I think my model of Eden the one in my head is now incorrect . 4.3 to 5 is unexciting but Spain revenue starts in 25 too so I don't get 5 at all.
alchemy
09/11/2024
08:04
Investing,

Completely agree with you.

supersonico
09/11/2024
07:58
MNS

I suspect £5 million is extremely cautious. I imagine he is saying that to be protective around regulatory approvals for the three.

If Eden were lucky enough to get Esseva and Ecovelex pre-Christmas this year, I imagine that number would increase very nicely.

investingisatrickygame
09/11/2024
06:39
Investing yes, he says "These include, but are not limited to" the 3 named events. But 4.3m (FY24) to 5m (FY2025) with US market added. That's not a lot of excitement from the US.
money never sleeps
09/11/2024
05:40
Syngenta's Strategies to Increase Biologicals Adoption

In this interview, Matt Pickard, Head of Biologicals & Seedcare Europe at Syngenta, will discuss how to differentiate products, train sales teams, and provide services for the farmers etc., offering valuable experience to the companies in the industry to increase biologicals adoption.

supersonico
09/11/2024
05:19
Investingisatrickygame - 03 Nov 2024 - - 19051

MNS,

Super is suggesting that because the recent Viking video has not been released as a stand-alone promo video, that Ecovelex full approval is coming with new and appropriate media to launch the full regulatory aoproval.

We will see.

supersonico
09/11/2024
05:17
Viking watch.

'To make it possible for us to perceive and to comprehend things invisible, we are forced to conceptualize objects whose existence cannot be independently verified but can only be inferred from their observable influences similarly to the way physicists infer the existence of subatomic particles. ' Orlov 2024


No Sightings today but the 'outlook' commentary of 'EU-wide approval of Ecovelex' on it's timetable 2025+ 'Very soon' anticipated arrival was noted also noted was Smith not commenting on Ecovelex 2025 @8 Nov 2024 Proactive. Changes in habitual qualification are observable signals / patterns from which information can be inferred.

supersonico
08/11/2024
20:20
The share price chart has responded accordingly, I note. Hahahahaahahaaa!!


AND this is despite all the ramping lies by trapped bulls as well as paid propagandists!

neutralpov
08/11/2024
17:10
So the whole of Spain worth less than a mill?
alchemy
08/11/2024
17:09
I found it a little honeyed. 5million next year still consuming cash . Not in line with the excitement line?Mind you I'll add if I can at 3.3333334
alchemy
08/11/2024
16:01
"Major players such as BASF SE, Bayer AG, Syngenta & FMC Corporation are investing heavily in this sector, with strategic product launches, acquisitions & digital partnerships signaling an exciting future"

Hopefully, Eden will be one of those acquisition targets within the next 2 years

investingisatrickygame
08/11/2024
15:43
Biopesticides market is expected to soar to $15.6 billion by 2029, driven by a robust CAGR of 15.9%

This growth reflects a shift among health-conscious consumers, environmental advocates & a forward-thinking agricultural sector eager for sustainable change

Imagine the natural fungus Beauveria bassiana taking down the destructive Western flower thrips, pests responsible for yearly crop losses of $5 billion

Health & environmental concerns around synthetic pesticides push farmers & consumers toward safer, natural alternatives

Yet, the biopesticide industry faces notable challenges: short shelf lives, higher costs, lengthy regulatory processes & compatibility issues with existing agricultural products

Emerging regions like Asia-Pacific & South America are quickly becoming key growth markets, with rising incomes, population increases & heightened demand for organic food propelling the industry forward

Innovative technologies are revolutionizing the biopesticide landscape

Nanoformulations, microencapsulation, RNA interference (RNAi) & drone-assisted applications are expanding the potential of biopesticides while advanced genetic engineering redefines sustainable pest control

Liquid-stable formulations enhance ease of use, making biopesticides more accessible to farmers

Bioinsecticides are gaining traction across high-value crops & turf applications

Major players such as BASF SE, Bayer AG, Syngenta & FMC Corporation are investing heavily in this sector, with strategic product launches, acquisitions & digital partnerships signaling an exciting future

The investment potential in safer, more field-friendly biopesticides is substantial

Biopesticides market is poised for transformation, driven by rising global demand, breakthrough formulations & a collective drive for sustainable agriculture.

Dr Minshad Ali Ansari

supersonico
Chat Pages: 786  785  784  783  782  781  780  779  778  777  776  775  Older

Your Recent History

Delayed Upgrade Clock